Analysis of the clinical value of Baogan Lishui decoction and convetional western medicine in treating Hepatitis B cirrhosis refractory ascites

Abstract

Objective: To investigate the clinical effect of combination treatment of Chinese medicine Baogan Lishui decoction and western medicine on hepatitis B cirrhosis related refactory ascites.

Method: Control group was given conventional western medicine therapy while the observation group was given same conventional western medicine therapy with additional of Chinese medicine Baogan Lishui decoction.

Result: The total effective of clinical treatment on hepatitis B cirrhosis related refractory ascites in observation group was higher than that of the control group which was 88.89% compared to 71.11%, respectively and it was significant different (p<0.05).

Conclusion: The combination treatment of Chinese medicine Baogao Lishui decoction and conventional western medicine can significantly increased the treatment effect on hepatitis B cirrhosis refractory ascites, and thus increases the quality and safety of life.

References

Ma Yue, Ren Yanyi, Zhang Fan. Clinical analysis of the treatment of refractory ascites in patients with hepatitis B cirrhosis by integrated traditional Chinese and Western medicine [J]. Asia-Pacific Traditional Medicine, 2015, 11(19): 97-98

State Administration of Traditional Chinese Medicine. Guiding Principles for Clinical Research of New Drugs in Traditional Chinese Medicine [S]. Beijing: China Medical Science and Technology Press, 2002: 233-237, 386.

Ren Zhiqiang, Fu Yafang. Clinical evaluation of integrated traditional Chinese and western medicine in the treatment of patients with refractory ascites due to hepatitis B cirrhosis[J]. TCM Clinical Research, 2014, 6(33): 56-58.

Zhou Huaibing. Clinical observation on the treatment of refractory ascites in patients with hepatitis B cirrhosis by integrated traditional Chinese and Western medicine [J]. Shenzhen Journal of Integrated Traditional Chinese and Western Medicine, 2015, 25(10): 179-180.